Related Experiment Video
Updated: Jul 17, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Frequency of Familial Mediterranean Fever Gene Mutation in Patients Presenting With Joint Pain and Diagnosed With
Ufuk U Gullu1, İsmail Balaban2, Soner Sertan Kara3
1Pediatric Cardiology, Hatay Mustafa Kemal University, Hatay, TUR.
Abstract:
Introduction Acute rheumatic fever (ARF) is a non-suppurative systemic inflammatory disease that manifests 1-5 weeks following a Group A beta-hemolytic streptococcal infection. On the other hand, familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease characterized as an autosomal recessive disease, with affected individuals having pathogenic mutations in the Mediterranean fever gene (MEFV) gene located on the short arm of chromosome 16. FMF and ARF have overlapping symptoms and signs, and both disorders are common in Turkey. In ARF, the target organ is the heart, while in FMF, the target organ is the kidney; both organs can benefit from prophylactic measures. Our study aims to determine the frequency of the FMF gene mutation in patients with ARF in Turkey and detect any overlapping conditions. Method Patients who were diagnosed with a first-attack ARF between May 2015 and May 2018 were retrospectively screened. Patients who underwent MEFV gene analysis considering FMF in the differential diagnosis were included in the study. Results In this study, no statistical difference was found between the presence of MEFV gene mutations, carditis, high anti-streptolysin-O antibody (ASO) levels, and the groups with monoarthritis, polyarthritis, and polyarthralgia (p >0.05). Conclusions In conclusion, patients with ARF should be evaluated for FMF to avoid irreversible complications.
Insights
Familial Mediterranean fever (FMF) gene mutations were investigated in acute rheumatic fever (ARF) patients. No significant difference was found, suggesting ARF patients need FMF evaluation to prevent complications.
Area of Science:
- Rheumatology
- Genetics
- Internal Medicine
Background:
- Acute rheumatic fever (ARF) is an inflammatory disease following Group A streptococcal infection.
- Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder caused by MEFV gene mutations.
- Both ARF and FMF are prevalent in Turkey and share overlapping symptoms, complicating diagnosis.
Purpose of the Study:
- To determine the frequency of MEFV gene mutations in Turkish patients diagnosed with ARF.
- To identify potential overlapping conditions between ARF and FMF in this population.
Main Methods:
- Retrospective screening of ARF patients diagnosed between May 2015 and May 2018.
- Inclusion of patients who underwent MEFV gene analysis for differential diagnosis of FMF.
Main Results:
- No statistically significant difference was observed in the presence of MEFV gene mutations among ARF patients.
- The study found no statistical correlation between MEFV mutations and carditis, elevated ASO levels, or specific arthritis types (monoarthritis, polyarthritis, polyarthralgia).
Conclusions:
- The findings suggest that MEFV gene mutations do not significantly differ in ARF patients compared to the general population.
- It is recommended that patients diagnosed with ARF undergo evaluation for FMF to prevent irreversible organ damage, particularly in high-prevalence regions like Turkey.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Point and Frameshift Mutations
The JAK-STAT Signaling Pathway

